New CPT Code Has Been Approved by the AMA for Transperineal Laser Ablation of the Prostate
November 1, 2021 Effective from July 1, 2022, the specific CPT code will allow EchoLaser SoracteLite treatment to spread quickly, with benefits for hospitals, payers and most of all patients. Click here to get more details.
20 Italian IEA Congress
September 6-8, 2021, Bari - Italy The 20th edition of the Italian Endourology Association will be held on September 6-8 at The Nicolaus Hotel of Bari, during the event SoracteLite procedure for the treatment of benign prostatic hyperplasia will be presented by Dr....
ICEP Web Course – 1st presentation of MRI-g SoracteLite focal treatment for PCa
October 17, 2020 Elesta is proud to announce the first presentation of MRI guided SoracteLite focal laser ablation for prostate cancer. The pre-recorded video will be presented on Saturday 17 October at 11.00 during ICEP2020 web course. Click here to access to access...
A new publication on SoracteLite is in press!
The article reports the experience of the Urology Unit of Bari University, showing good results at 6 months in efficacy, safety and ejaculation preservation. Moreover, all patients but one discontinued medical therapy. Click here to read the abstract.
SoracteLite presented on Odeon TV
August 29, 2020 Professor Novello Pinzi describes SoracteLite procedure and related clinical advantages for the patient. Click here to see the interview.